(Q48088431)

English

Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis.

scientific article published on 23 March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/28332724

Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis. (English)

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/28332724

Alessandro Broccoli

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Pier Luigi Zinzani

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Vittorio Stefoni

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Letizia Gandolfi

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

23 March 2017

1 reference

Europe PubMed Central

8 February 2018

http://europepmc.org/abstract/MED/28332724

Hematological Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

36

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

136-143

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Biosimilars: what clinicians should know

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Use of biosimilar epoetin to increase hemoglobin levels in patients with chemotherapy-induced anemia: real-life clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: a simulation for the EU G5 countries

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

The approval process for biosimilar erythropoiesis-stimulating agents

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Erythropoietin or Darbepoetin for patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Biosimilar versus patented erythropoietins: learning from 5 years of European and Japanese experience

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Biosimilars: the science of extrapolation

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

21 January 2018

Cancer- and chemotherapy-induced anemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased erythropoietin response in patients with the anemia of cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

7 January 2021

based on heuristic

inferred from DOI database lookup

Update on safety of ESAs in cancer-induced anemia

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

7 January 2021

based on heuristic

inferred from DOI database lookup

Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

7 January 2021

based on heuristic

inferred from DOI database lookup

Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP

1 reference

https://api.crossref.org/works/10.1002%2FHON.2412

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.2412

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28332724%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48088431&oldid=1464979985"